04/26/2017
https://www.congress.gov...
"Do you believe that smaller firms should have the same opportunities as multitrillion-dollar firms to list exchange-traded products in order to compete and serve investors?"
"Thank you and Senator Blunt, for your leadership, and the success that we have had in numerous years."
"the $16.9 billion increase for NCI in fiscal year 2022, allowed the NCI to increase the funding allocated toward competitive cancer grants."
"Developing resilient space architecture is critical to the entire Joint Force. The growth of our competitors' capabilities in space have changed how we approach integrated deterrence and defense."